Until a coronavirus vaccine is ready, pneumonia vaccines may reduce deaths from COVID-19

A COVID-19 vaccine isn't the only tool for fighting this pandemic. An immunologist argues that safe pneumonia vaccines would reduce the severity of COVID-19, save lives and prevent the worst cases.

Robert Root-Bernstein, Professor of Physiology, Michigan State University • conversation
Oct. 14, 2020 ~10 min

Tags:  influenza  covid-19  pandemic  tuberculosis  vaccines  polio  sars-cov-2

Coronavirus: how the pharma industry is changing to produce a vaccine on time

Medical innovation is often accelerated in a time of crisis.

Stephen Morris, Research Fellow in Vaccine Process Analytics, UCL • conversation
Sept. 30, 2020 ~8 min

Tags: biotechnology covid-19 vaccines pharmaceuticals coronavirus-2020 pharmaceutical-industry coronavirus-vaccine

Your child's vaccines: What you need to know about catching up during the COVID-19 pandemic

A pediatrician answers parents' questions about catching up on missed childhood vaccinations and why that's so important.

Irène Mathieu, Pediatrician, Assistant Professor of Pediatrics, University of Virginia • conversation
Sept. 29, 2020 ~6 min

Tags: health public-health covid-19 schools pandemic health-care vaccines measles pediatric-care flu-shots childhood-vaccination

How and when will we know that a COVID-19 vaccine is safe and effective?

Several vaccines are in Phase 3 trials. So when will we know whether any of these will protect against COVID-19?

William Petri, Professor of Medicine, University of Virginia • conversation
Sept. 22, 2020 ~10 min

Tags: covid-19 immune-system pandemic fda vaccines sars-cov-2 phase-3-trial immune-response vaccine-trials covid-19-vaccine vaccine-safety vaccine-approval

COVID-19 vaccines: Open source licensing could keep Big Pharma from making huge profits off taxpayer-funded research

Governments must embrace policies that promote sharing and collective invention to create and distribute a vaccine quickly.

Timothy Ford, Professor and Chair of Biomedical and Nutritional Sciences, University of Massachusetts Lowell • conversation
Sept. 18, 2020 ~9 min

Tags:  health  medicine  covid-19  pandemic  vaccines  sars-cov-2  open-source  innovation-and-invention  process-of-innovation

Video: Who should get a COVID-19 vaccine first?

A bioethicist explains a recent report that recommends how to distribute a COVID-19 vaccine equitably.

Nicole Hassoun, Professor of Philosophy, Binghamton University, State University of New York • conversation
Sept. 18, 2020 ~8 min

Tags:  public-health  covid-19  coronavirus  vaccines  patents  big-pharma

Keeping coronavirus vaccines at subzero temperatures during distribution will be hard, but likely key to ending pandemic

The cold supply chain keeps vaccines fresh during distribution, but the current system is nowhere near large enough to distribute the billions of COVID-19 vaccines that the world needs.

Anna Nagurney, John F. Smith Memorial Professor of Operations Management, University of Massachusetts Amherst • conversation
Sept. 18, 2020 ~10 min

Tags: covid-19 coronavirus vaccines immunity supply-chains cold-chain distribution trucks

Coronavirus nanoscience: the tiny technologies tackling a global pandemic

Nanotechnology has an impressive record against viruses.

Josh Davies, PhD Candidate in Chemistry, Cardiff University • conversation
Sept. 7, 2020 ~7 min

Tags: covid-19 coronavirus nanotechnology vaccines antibodies ppe nanomedicine medical-diagnosis diagnostic-test

Vaccines often degrade in the heat: here's how our new chemical 'casing' could save lives

A new way of getting functioning vaccines to where they are needed.

Aswin Doekhie, Postdoctoral Research Associate, University of Bath • conversation
Sept. 4, 2020 ~6 min

Tags:  medicine  covid-19  vaccines  cold-chain

Page 1 of 6